- Investing Ideas
- South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
1 new
High return on equity, past performance and sound balance sheet.
2 companies
ALTEOGEN
Market Cap: ₩18.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩364,500.00
7D
-1.2%
1Y
12.8%
Samsung BiologicsLtd
Market Cap: ₩64.6t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
New
A207940
₩1,415,000.00
7D
-0.3%
1Y
-9.4%